14.Jun.2018

OCT is among Top 3 CRO's according to ACTO report

The Association of Clinical Trials Organizations has prepared a summary report for 2017
According to the results of the report, OCT holds holds а 3rd place among the received approvals for conducting local clinical trials and bioequivalence studies.

http://acto-russia.org/files/ACTO_Newsletter_16.pdf